Earnings Call: INmune Bio Q3 2024 Results Show Progress in Clinical Trials

InvestingNov 1 22:42

BTIG Maintains INmune Bio(INMB.US) With Buy Rating, Maintains Target Price $21

Futu NewsNov 1 20:35 · Ratings

INmune Bio, Inc. (INMB) Q3 2024 Earnings Call Transcript Summary

Futu NewsNov 1 08:47 · Conference Call

INmune Bio GAAP EPS of -$0.60 Misses by $0.10

Seeking AlphaNov 1 04:12

INmune Bio | 10-Q: Q3 2024 Earnings Report

SECNov 1 04:06 · Announcements

Express News | INmune Bio Q3 Operating Income USD -12.286 Million

BreakingsNov 1 04:05